Telehealth company Ro said on Wednesday it will offer single-dose vials of Eli Lilly's (LLY.N), opens new tab weight-loss drug Zepbound to patients with obesity, becoming the first alternative platform for the lower-cost version of the drug to Lilly's own website.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,